Humacyte Q4 Financial Results and Cash Position
Friday, 22 March 2024, 11:20
Humacyte Q4 Financial Results Summary
Humacyte press release (HUMA): Q4 GAAP EPS of -$0.24 in-line. The company reported cash and cash equivalents of $80.4 million as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.